WELLS FARGO & COMPANY/MN
Position in RARE — Ultragenyx Pharmaceutical Inc.
CIK 72971
SAN FRANCISCO, CA
Position in RARE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,263,697
+$3,823,072 QoQ
Shares Held
157,643
+129.2% QoQ
Ownership
0.160%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 311 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in RARE Over Time
Shares Held
Position Value (USD)
Derivatives in RARE
reported options exposure · as of Mar 31, 2022CallValue
$0
CallShares
0
PutValue
$14,524
PutShares
200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. RARE ranks #59 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in RARE
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,263,697 | 157,643 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,440,625 | 68,765 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $1,461,949 | 63,563 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $750,434 | 24,948 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $634,117 | 17,440 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $625,309 | 17,269 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,277,705 | 30,371 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,847,424 | 33,257 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,186,103 | 28,859 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,466,437 | 31,408 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $1,996,769 | 41,756 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $2,173,684 | 60,973 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,918,083 | 41,580 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,670,323 | 41,654 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $487,853 | 10,530 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $333,266 | 8,048 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $676,840 | 11,345 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $14,524 | 200 | Put | Defined | 2022-05-16 | |
| 2022-03-31 | $383,721 | 5,284 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $281,867 | 3,352 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $500,372 | 5,548 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,476,236 | 57,433 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $8,410,381 | 73,866 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $11,717,130 | 84,643 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $3,389,430 | 41,239 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $4,616,073 | 59,014 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,552,338 | 34,939 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||